New Nasdaq-Listed Company, Hyperliquid Strategies, to Hold $583M in HYPE Tokens
A new publicly traded company focused on crypto treasury management is set to emerge from a merger between the Nasdaq-listed Sonnet BioTherapeutics Holdings and Rorschach I LLC. The new, combined entity, named Hyperliquid Strategies Inc. (HSI), will control $888 million in total assets. This includes a large allocation of the HYPE token and over $300 […]
The post New Nasdaq-Listed Company, Hyperliquid Strategies, to Hold $583M in HYPE Tokens appeared first on Coin Edition.